Business Description
Can Fite Biofarma Ltd
ISIN : IL0010944739
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 224.36 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -21.91 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -37 | |||||
3-Year EBITDA Growth Rate | 45.3 | |||||
3-Year EPS without NRI Growth Rate | 37.1 | |||||
3-Year FCF Growth Rate | 41.7 | |||||
3-Year Book Growth Rate | -29.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.89 | |||||
9-Day RSI | 54.22 | |||||
14-Day RSI | 51.75 | |||||
12-1 Month Momentum % | 16.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.9 | |||||
Quick Ratio | 4.9 | |||||
Cash Ratio | 4.42 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -43.1 | |||||
Shareholder Yield % | 0.28 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1103.47 | |||||
Net Margin % | -1027.89 | |||||
FCF Margin % | -1136.32 | |||||
ROE % | -121.88 | |||||
ROA % | -72.07 | |||||
ROIC % | -721.45 | |||||
ROC (Joel Greenblatt) % | -7519.72 | |||||
ROCE % | -99.68 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 9.33 | |||||
PB Ratio | 1.65 | |||||
Price-to-Tangible-Book | 1.35 | |||||
EV-to-EBIT | -0.24 | |||||
EV-to-EBITDA | -0.24 | |||||
EV-to-Revenue | 2.65 | |||||
EV-to-Forward-Revenue | 0.44 | |||||
EV-to-FCF | -0.28 | |||||
Price-to-Net-Current-Asset-Value | 1.35 | |||||
Price-to-Net-Cash | 2.7 | |||||
Earnings Yield (Greenblatt) % | -416.27 | |||||
FCF Yield % | -78.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Can Fite Biofarma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 2.748 | ||
EPS (TTM) (₪) | -0.037 | ||
Beta | 0 | ||
Volatility % | 56.25 | ||
14-Day RSI | 51.75 | ||
14-Day ATR (₪) | 0.00114 | ||
20-Day SMA (₪) | 0.02655 | ||
12-1 Month Momentum % | 16.67 | ||
52-Week Range (₪) | 0.023 - 0.041 | ||
Shares Outstanding (Mil) | 1,497.13 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Can Fite Biofarma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Can Fite Biofarma Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
Can Fite Biofarma Ltd Frequently Asked Questions
What is Can Fite Biofarma Ltd(XTAE:CANF)'s stock price today?
When is next earnings date of Can Fite Biofarma Ltd(XTAE:CANF)?
Does Can Fite Biofarma Ltd(XTAE:CANF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |